ANALYSIS OF HEMATOLOGICAL CHANGES IN TOFACITINIB-TREATED PATIENTS WITH ULCERATIVE COLITIS ACROSS PHASE 3 INDUCTION AND MAINTENANCE STUDIES

被引：0
|
作者：
Lichtenstein, Gary R.
Moore, Gregory T.
Soonasra, Arif
Nduaka, Chudy I.
Kwok, Kenneth
Wang, Lisy
Lawendy, Nervin
Chan, Gary
Su, Chinyu
Loftus, Edward V.
机构：
来源：
GASTROENTEROLOGY | 2019年 / 156卷 / 06期
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
Tu1752
引用
收藏
页码：S1111 / S1111
页数：1
相关论文
共 50 条
  • [21] MAINTENANCE OF QUALITY OF LIFE IMPROVEMENT IN A PHASE 3 STUDY OF TOFACITINIB FOR PATIENTS WITH MODERATELY TO SEVERELY ACTIVE ULCERATIVE COLITIS
    Panes, Julian
    Rubin, David T.
    Vermeire, Severine
    Lindsay, James O.
    Sands, Bruce E.
    Su, Chinyu
    Friedman, Gary
    Zhang, Haiying
    Kayhan, Cem
    Manuchehri, Alireza
    Healey, Paul J.
    GASTROENTEROLOGY, 2017, 152 (05) : S601 - S602
  • [22] Improvement in Patient-Reported Outcomes in Two Phase 3 Induction Studies of Tofacitinib in Patients With Moderately to Severely Active Ulcerative Colitis
    Panes, Julian
    Su, Chinyu
    Marren, Amy
    Yu, Dahong
    Woodworth, Deborah A.
    Zhang, Haiying
    Healey, Paul J.
    GASTROENTEROLOGY, 2016, 150 (04) : S1003 - S1003
  • [23] Adalimumab induction and maintenance therapy for patients with ulcerative colitis previously treated with infliximab
    Taxonera, C.
    Estelles, J.
    Fernandez-Blanco, I.
    Merino, O.
    Marin-Jimenez, I.
    Barreiro-de Acosta, M.
    Saro, C.
    Garcia-Sanchez, V.
    Gento, E.
    Bastida, G.
    Gisbert, J. P.
    Vera, I.
    Martinez-Montiel, P.
    Garcia-Moran, S.
    Sanchez, M. C.
    Mendoza, J. L.
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2011, 33 (03) : 340 - 348
  • [24] Analysis of immunological VAriables in ex vivo Tofacitinib-treated human biopsies from Active ulcerative colitis patients to predict clinical Response (the AVATAR study)
    Onali, S.
    Di Petrillo, A.
    Soddu, P.
    Ibba, I.
    Demurtas, M.
    Raho, N.
    Morrocchi, E.
    Amodio, D.
    Palma, P.
    Milenkovic, S.
    Ceccarelli, M.
    Fantini, M. C.
    JOURNAL OF CROHNS & COLITIS, 2024, 18 : I1048 - I1049
  • [25] Tofacitinib Induction Therapy Reduces Symptoms Within 3 Days for Patients With Ulcerative Colitis
    Hanauer, Stephen
    Panaccione, Remo
    Danese, Silvio
    Cheifetz, Adam
    Reinisch, Walter
    Higgins, Peter D. R.
    Woodworth, Deborah A.
    Zhang, Haiying
    Friedman, Gary S.
    Lawendy, Nervin
    Quirk, Daniel
    Nduaka, Chudy I.
    Su, Chinyu
    CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 2019, 17 (01) : 139 - 147
  • [26] Exposure-Response Characterization of Tofacitinib Efficacy in Moderate to Severe Ulcerative Colitis: Results From Phase II and Phase III Induction and Maintenance Studies
    Mukherjee, Arnab
    Tsuchiwata, Shinichi
    Nicholas, Timothy
    Cook, Jack A.
    Modesto, Irene
    Su, Chinyu
    D'Haens, Geert R.
    Sandborn, William J.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2022, 112 (01) : 90 - 100
  • [27] Diagnostic accuracy of rectal bleeding and stool frequency in predicting mucosal healing in patients with ulcerative colitis in the tofacitinib OCTAVE Phase 3 induction studies
    Colombel, J. F.
    Bushmakin, A. G.
    Cappelleri, J. C.
    Kulisek, N.
    Santana, G. O.
    Lawendy, N.
    Ponce de Leon, D.
    Lakatos, P. L.
    JOURNAL OF CROHNS & COLITIS, 2020, 14 : S328 - S329
  • [28] DIAGNOSTIC ACCURACY OF RECTAL BLEEDING AND STOOL FREQUENCY IN PREDICTING MUCOSAL HEALING IN PATIENTS WITH ULCERATIVE COLITIS IN THE TOFACITINIB OCTAVE PHASE 3 INDUCTION STUDIES
    Colombel, Jean Frederic
    Bushmakin, Andrew G.
    Cappelleri, Joseph C.
    Kulisek, Nicole
    Santana, Genoile O.
    Lawendy, Nervin
    de Leon, Dario Ponce
    Lakatos, Peter L.
    GASTROENTEROLOGY, 2020, 158 (06) : S1203 - S1203
  • [29] Tofacitinib induction and maintenance therapy in East Asian patients with active ulcerative colitis: subgroup analyses from three phase 3 multinational studies (vol 16, pg 233, 2018)
    Motoya, Satoshi
    Watanabe, Mamoru
    Kim, Hyo Jong
    Kim, Young Ho
    Han, Dong Soo
    Yuasa, Hirotoshi
    Tabira, Junichi
    Isogawa, Naoki
    Arai, Shoko
    Kawaguchi, Isao
    Hibi, Toshifumi
    INTESTINAL RESEARCH, 2018, 16 (03) : 499 - 501
  • [30] Onset of Efficacy of Tofacitinib for Induction Therapy in Patients with Active Ulcerative Colitis in Two Multinational, Phase 3 Clinical Trials
    Sandborn, William J.
    Danese, Silvio
    Panes, Julian
    Zhang, Haiying
    Woodworth, Deborah
    Marren, Amy
    Su, Chinyu
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2016, 111 : S260 - +
12345